Patent: 10,039,816
✉ Email this page to a colleague
Summary for Patent: 10,039,816
| Title: | Siderophore-based immunization against gram-negative bacteria |
| Abstract: | The present invention provides novel enterobactin-carrier protein conjugates and salmochelin-carrier protein conjugates, such as compounds of Formula (I), and salts thereof. The present invention also provides compositions, kits, and methods that involve the compounds of Formula (I) and are useful in inducing an immune response, treating a bacterial infection and/or inflammatory bowel disease in a subject, preventing a bacterial infection and/or inflammatory bowel disease in a subject, or inhibiting the growth of or killing a bacterium. |
| Inventor(s): | Elizabeth Marie Nolan, Phoom Chairatana, Manuela Raffatellu, Martina Sassone Corsi, Araceli Perez-Lopez |
| Assignee: | Massachusetts Institute of Technology , University of California San Diego UCSD |
| Application Number: | US14/700,397 |
| Patent Claims: | see list of patent claims |
| Patent landscape, scope, and claims summary: |
More… ↓ |
Details for Patent 10,039,816
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Novo Nordisk Inc. | TRESIBA | insulin degludec | Injection | 203314 | September 25, 2015 | 10,039,816 | 2035-04-30 |
| Novo Nordisk Inc. | TRESIBA | insulin degludec | Injection | 203314 | November 21, 2018 | 10,039,816 | 2035-04-30 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,039,816
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2015168380 | ⤷ Start Trial |
| United States of America | 2016022794 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
